Year: 2020

The strength of the U.S. consumer will be the key focus this week for markets. …read more […]

Bitcoin Cash split into two blockchain again, but one of the new chain has received no hashpower so far. …read more […]

It’s too early to know if these proposals will ever get enacted, especially if Republicans hold onto the Senate, but a few would affect many Americans. …read more […]

Biotech stocks advanced in the week ended Nov. 13 amid a vaccine news flow-induced rally that also lifted the broader market.The week started with positive tidings from Pfizer Inc. (NYSE: PFE) and its German partner BioNTech SE – ADR (NASDAQ: BNTX), which reported positive interim Phase 3 data for their jointly developed mRNA vaccine against the COVID-19 coronavirus.An update from rival vaccine developer Moderna Inc (NASDAQ: MRNA) on reaching the mandated number of cases for its first interim analysis also generated optimism.Five Prime Therapeutics Inc (NASDAQ: FPRX) rallied over 300% during the week, with the upside primarily due to …read more […]

Shareholders in NewAge, Inc. (NASDAQ:NBEV) may be thrilled to learn that the analysts have just delivered a major… …read more […]

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) shareholders will have a reason to smile today, with the analysts making… …read more […]

…read more […]

3M Company (NYSE:MMM) is about to trade ex-dividend in the next 3 days. You can purchase shares before the 19th of… …read more […]

Every investor in Gevo, Inc. (NASDAQ:GEVO) should be aware of the most powerful shareholder groups. Insiders often own… …read more […]

It’s been a good week for Charlotte’s Web Holdings, Inc. (TSE:CWEB) shareholders, because the company has just… …read more […]

The pharmaceutical industry has made a last-ditch C$1 billion ($761 million) proposal to the Canadian government in hopes of fending off parts of a drug pricing crackdown set to go into effect on Jan. 1, according to industry documents reviewed by Reuters. The remaining regulations would still reduce drugmakers’ revenue by at least C$19.8 billion ($15.1 billion) over 10 years, according to an industry estimate. If other costly reforms are shelved, the industry is willing to spend C$1 billion over the same period to boost local manufacturing and commercialization, and on new programs to improve access to …read more […]

If you want to know who really controls CureVac N.V. (NASDAQ:CVAC), then you’ll have to look at the makeup of its… …read more […]

Concerns over vaccine storage and distribution amid unprecedented global demand are weighing on the anticipation of a vaccine from Pfizer and BioNTech — even as the companies prepare to fulfill commitments of dose delivery by the end of 2020. …read more […]

The global coronavirus pandemic has created a huge spike in mental health conditions that psychedelic drugs can treat. …read more […]

It’s been a pretty great week for Cisco Systems, Inc. (NASDAQ:CSCO) shareholders, with its shares surging 10% to… …read more […]